Mark Reisman, M.D., is an interventional cardiologist with the Swedish Heart & Vascular Institute (SHVI). He is director of the medical center's Cardiovascular Research & Education program and Cardiac Catheterization Lab on Swedish's First Hill Campus.

Since joining Swedish's medical staff in 1995, Dr. Reisman has been the site principal investigator on more than 50 clinical trials. In addition, he has been a national Principal Investigator on several trials involving emerging technologies and innovations in neurovascular as well as the structural heart disease area.

Beside his roles at Swedish, Dr. Reisman has been a clinical assistant professor of medicine at the University of Washington since 1995.